About Dr. Lavanya Singhsinghl@ukzn.ac.za +27 (0) 31 240 1887
I have been trained as a Medical Scientist working in a diagnostic Virology laboratory for the past 10 years. I recently completed my PhD (UKZN) which focused on the development and evaluation of novel peptide inhibitors of HIV integrase using gold nanoparticles and targeted delivery. My Masters research looked at the molecular epidemiology of HIV-2 infection in KZN, SA, and was done under the supervision of Prof. Tulio de Oliveira.
Post-Doctoral Fellow: College of Health Sciences, University of KwaZulu-Natal (UKZN), Durban, South Africa.
PhD - Virology
MMedSc - Virology (summa cum laude)
BSc - Hons (Microbiology)
BSc (Genetics and Microbiology)
Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5
Targeted Sanger sequencing to recover key mutations in SARS-CoV-2 variant genome assemblies produced by next-generation sequencing.
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests..
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.
HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral treatment in KwaZulu-Natal Province, South Africa.
Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa..
Track Omicron’s spread with molecular data.
Rapid replacement of the Beta variant by the Delta variant in South Africa.
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
Implementation of an efficient SARS-CoV-2 specimen pooling strategy for high throughput diagnostic testing.
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
Transmission dynamics of SARS-CoV-2 within-host diversity in two major hospital outbreaks in South Africa.
Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection.
A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa.
High Resolution analysis of Transmission Dynamics of Sars-Cov-2 in Two Major Hospital Outbreaks in South Africa Leveraging Intrahost Diversity.
Whole Genome Sequencing of SARS-CoV-2: Adapting Illumina Protocols for Quick and Accurate Outbreak Investigation During a Pandemic.
Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report.
Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa.
High Level of HIV-2 False Positivity in KwaZulu-Natal Province: A Region of South Africa With a Very High HIV-1 Subtype C Prevalence.